Cancer Grand Challenges’ Post

canSERV’s #ServiceforProposal goes into the next round!🥳 📣 NEXT WEEK #canSERV_EU will launch its OPEN CALL on “Transnational Service Provision”! 🎗 Under this call, #CancerResearchers are welcome to apply to a portfolio of services offered by canSERV to address the research needs of the entire #oncology developmental pipeline. Stay tuned for more information and the application form. 🙌 Why canSERV? ➡ canSERV is a collaborative project of complementary life science research infrastructures providing free-of-charge access to cancer research services, tools and guidance to accelerate oncology research to foster. #EUCancerPlan #EUCancerMission #ResearchServices #ResearchInfrastructure Project partners: BBMRI-ERIC, EATRIS, ECRIN (European Clinical Research Infrastructure Network), ELIXIR, Euro-BioImaging, EU-OPENSCREEN, EurOPDX Research Infrastructure, EMBRC - European Marine Biological Resource Centre, IBISBA / Wageningen University & Research, INFRAFRONTIER, Instruct-ERIC, MIRRI - Microbial Resource Research Infrastructure / Universidade do Minho, EORTC - European Organisation for Research and Treatment of Cancer, IARC - International Agency for Research on Cancer / World Health Organization, #CancerCoreEurope, European Cancer Patient Coalition , #ARIE (Analytical Research Infrastructures in Europe), ttopstart , ARTTIC Innovation GmbH

✨The Puerto Rico Innovation Fund is thrilled to announce a significant stride in our mission to foster local innovation: a $750K financing facility has been successfully funded for a pioneering Puerto Rico subsidiary focused on developing novel cancer therapeutics. This investment isn't just a financial commitment; it’s a testament to our belief in the potential of Puerto Rico's scientific community. The funding will facilitate the creation of new job opportunities on the Island, specifically targeting talented cancer researchers. We're proud to play a role in supporting groundbreaking clinical processes that could pave the way for breakthroughs in cancer treatment.🔬 ⏩️Our commitment to the innovation ecosystem of Puerto Rico remains steadfast. In line with this, we are excited to reveal our goal to deploy an additional $12.5 million between January and February of 2024. This is more than an investment in a company; it’s an investment in the future of Puerto Rican science, health, and prosperity. Together, we are not just advancing medical science; we are nurturing a community of innovators and contributing to a healthier tomorrow.🌟 #PRIF #Innovation #CancerResearch #PuertoRico #HealthcareInnovation #EconomicGrowth #ClinicalResearch #InvestmentInScience

Today, On National Cancer Awareness Day 2023, let's stand together and let's raise our voices, spread awareness, and support those on their journey to recovery. ADYPU, School of Engineering offers programs like Cancer Biology under their Biotechnology course. Together, we can make a difference. 💪🎗️ #AjeenkyaDYPatil #DrAjeenkyaDYPatil #ADYPU #AjeenkyaDYPatilUniversity #CancerAwareness #NationalCancerAwarenessDay #BestUniversities #TopUniversities #EngineeringEducation #EngineeringStudent #Biotechnology #EngineeringProblemSolving #EngineeringLeadership #EngineeringInnovation #EngineeringCareers #EngineeringCommunity

Cold Spring Harbor Laboratory (CSHL) researchers reveal MED12 as key player in basal-like pancreatic cancer. For years, researchers have wondered exactly how this deadly disease, known as basal-like pancreatic cancer, works. Now, Diogo Maia-Silva, MD PhD and colleagues at CSHL have discovered that a protein called MED12 may play a critical role. While the discovery is notable in and of itself, it also builds on decades of CSHL research. Read: https://lnkd.in/ej95Cwhn #sciencesdelavie #biotechnology #biotechnology #innovation #innovations #research #sciences #medicaments #research #drugresearch #laboratories #labs #chemistry #chemistry #biology #biologie #biopharma #rna #rnatherapeutics #arn #revolution #happy

Cold Spring Harbor Laboratory (CSHL) researchers reveal MED12 as key player in basal-like pancreatic cancer. For years, researchers have wondered exactly how this deadly disease, known as basal-like pancreatic cancer, works. Now, Diogo Maia-Silva, MD PhD and colleagues at CSHL have discovered that a protein called MED12 may play a critical role. While the discovery is notable in and of itself, it also builds on decades of CSHL research. Read: https://lnkd.in/eYU6WNiB #sciencesdelavie #biotechnology #biotechnology #innovation #innovations #research #sciences #medicaments #research #drugresearch #laboratories #labs #chemistry #chemistry #biology #biologie #biopharma #rna #rnatherapeutics #arn #revolution #happy

🚀 Exciting Update Alert! 🌟The European Patent Office has highlighted the top innovators in cancer research across Europe! We're all about staying in the know, especially when it comes to game-changing strides in fighting cancer. And guess what? As per the European Patent Office's latest report, three countries are leading the charge: 🥇 Germany 🥈 United Kingdom 🥉 France 📈 This study offers valuable insights into the technology landscape and recent innovation trends in cancer combat. Utilizing global patent data, it presents a comprehensive analysis of cancer-related patents, covering various technologies crucial for diagnosis, prevention, treatment, and potential cure. 💡 Explore how patents play a pivotal role in shaping the future of healthcare. Contact us today to assist you in studying your patents and navigating the world of intellectual property! ☎️: 05 20 30 55 50 📧: contact@ipafrica.net 🌍: https://zurl.co/2B0a 🔗 Link for the full study : https://zurl.co/GshB #CancerInnovation #Europe #Healthcare #IPAFRICA #IPP #EuropeanPatentOffice #Science #Technology #IPCase #IntellectualProperty # #Conseillerenproprieteindustrielle #Germany #UK #France #Brevet #BrevetPharmaceutique

Announcement: Overarching agreement with Dundee University and Initiation of Evaluation project.    We are thrilled to announce the signature of an over-arching agreement with the University of Dundee and their Drug Discovery Unit, University of Dundee (DDU) to access research relating to novel therapeutic candidates.    The first Evaluation Agreement under the framework focuses on investigating a lead series of therapeutic candidates in the increasingly important research area of pro-senescence (selectively promoting ageing of cancer cells to cease growth in tumours). This exciting area of research has the potential to be effective in treating multiple cancer types, and also many other disease areas, including those associated with healthy ageing.    This work builds upon previous ground-breaking research by Dundee and Barts Charity funded research by Prof Cleo Bishop, Professor of Senescence and Director of the Queen Mary University of London Phenotypic Screening Facility.    Speaking about the agreement, ValiRx CEO Dr Suzy Dilly said: "We are delighted to be able to streamline the process of reviewing and accessing the excellent research from the University of Dundee's DDU, which will help to bring on evaluation projects more quickly."    Professor David Gray, Head of Biology and innovative targets portfolio lead at the DDU commented "We are delighted that our UKRI Impact Accelerator Award has enabled us to translate the groundbreaking work of our collaborator Cleo Bishop at Queen Mary University London, to the point where ValiRx see the potential for treating patients."    Watch the announcement video, recorded by BRR Media, where ValiRx CSO Dr Cathy Tralau-Stewart explains the agreement in more detail: https://lnkd.in/gVcwHvPZ   #Assays #AssayDevelopment #BioTech #DrugDiscovery #CancerResearch #ScientificResearch

Living in Paris: Imagine going for a casual neighborhood apero and meeting an Italian researcher specializing in cancer and immunotherapy, holding a PHD in molecular medicine 🇮🇹 🎓 As Gaetano moved to France through his studies, and considering my project Tell Me Panda focuses on studies and careers abroad, I couldn't help but invite him to my YouTube channel to share his remarkable scientific journey 🔬 This video is perfect for you if: 👉 You're interested in cancer and immunotherapy research. 👉 You're considering a scientific career path. 👉 You're a scientist planning a shift from academia to the private sector. 👉 You are curious about the cultural transition of Italians in France https://lnkd.in/dFGQzdq9

Gizachew Muluneh Amera is a Postdoc at the Computational Biology group at ICGEB Trieste and Assistant Professor at Wollo University and Bahir Dar University, Ethiopia 🇪🇹 At ICGEB, he uses advanced computational techniques against RNA-binding proteins to enhance the design and development of anticancer medicines. "RNA-binding proteins can be responsible for the onset of cancer by stabilizing or modifying miRNA. Even the best-developed inhibitors of these proteins to date show several limitations which need to be overcome before they are translated into clinics. In Dr. Silvano Piazza's group, we use high-throughput virtual screening approaches to identify promising anticancer lead candidates, aiming to contribute to the discovery and development of targeted, clinically meaningful anticancer drugs." During his BIOTECHNET fellowship at the ICGEB HQ, Gizachew aims to further develop his work with protein analysis for application in therapeutics🧫 Agenzia Italiana per la Cooperazione allo Sviluppo Wollo University Bahir Dar University Bahir Dar University Bahir Dar,Ethiopia #Ethiopia #cancer #anticancer #computationalbiology #rna #highthroughputscreening #therapeutics

🌟 We are thrilled to share the success of IPAS member Danielle Questiaux in securing a $196,248 Australian Economic Accelerator Seed Grant! Her project, "Rapid development of new medical treatment compounds from radioactive mine waste," aims to explore an innovative and cost-effective source of cancer radiotherapy drugs. Through the extraction of radioactive atoms known as radionuclides from radioactive mine waste, Danielle's project has the potential to contribute to alpha therapy—a form of cancer treatment—and diagnosis. This dual functionality could allow for both treatment and monitoring of the treatment's effectiveness. Read the University of Adelaide news article https://bit.ly/3QCt14b This Seed Grant is a testament to the project's potential and supports translation and commercialisation activities aligned with national research priorities. It's a significant step towards developing a pipeline from discovery to real-world impacts 🚀🔬 #IPASSuccess #ResearchInnovation Faculty of Sciences, Engineering and Technology #EconomicAcceleratorGrant #RealWorldApplications